Asian Legal Business: OMM, HSF Advise on Chinese Pharma Firm’s US$461 Million HK IPO

October 29, 2020

O’Melveny represented China-based Simcere Pharmaceutical Group in its HK$3.57 billion (US$460.6 million) Hong Kong IPO. Simcere Pharmaceutical supplies branded generic pharmaceuticals to the Chinese market, Asian Legal Business reported.

Asian Legal Business subscribers can read the full article here.